LICN — Lichen International Income Statement
0.000.00%
- $2.71m
- -$31.48m
- $39.76m
- 74
- 100
- 2
- 61
Annual income statement for Lichen International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 31.6 | 30.7 | 34.3 | 33.8 | 39.8 |
Cost of Revenue | |||||
Gross Profit | 19.3 | 18.8 | 20.5 | 20.2 | 24.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 21.9 | 21.9 | 23 | 23.2 | 27.5 |
Operating Profit | 9.73 | 8.79 | 11.3 | 10.6 | 12.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9.73 | 9 | 11.5 | 10.7 | 11.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.07 | 6.41 | 8.46 | 7.82 | 8.34 |
Net Income Before Extraordinary Items | |||||
Net Income | 7.07 | 6.41 | 8.46 | 7.82 | 8.34 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.07 | 6.41 | 8.46 | 7.82 | 8.34 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 53.4 | 48.4 | 63.9 | 69.5 | 64 |
Dividends per Share |